Staphylococcal nasal carriage of health care workers

Journal of the College of Physicians and Surgeons Pakistan

Volumn 20, Issue 7, 2010, Pages 439-443

  Akhtar, Naeem ^a  

^a RAWALPINDI MEDICAL COLLEGE   (Pakistan)

Author keywords

Antibiotic susceptibility; Decolonization; Health care workers; Nasal carriage; Staphylococci

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFACLOR; CEFALEXIN; CEFOTAXIME; CEFRADINE; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; ENOXACIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINCOMYCIN; MOXIFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; TETRACYCLINE; VANCOMYCIN;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DELIVERY ROOM; DISK DIFFUSION; DRUG SENSITIVITY; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL PERSONNEL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDWIFE; NONHUMAN; NOSE; NOSE SMEAR; NURSING STUDENT; OBSERVATIONAL STUDY; OPERATING ROOM; PAKISTAN; PHYSICIAN; PREVALENCE; STAFF NURSE; STAPHYLOCOCCAL NASAL CARRIAGE; STAPHYLOCOCCUS AUREUS; WARD;

ADULT; CARRIER STATE; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NOSE; PAKISTAN; PERSONNEL, HOSPITAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77955880535     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boyce JM. Epidemiology and prevention of nosocomial infections. In: Crossley KB, Archer GL, editors. The staphylococci in human disease. New York: Churchill Livingstone; 1997.p. 309-29.
2. Kluytmans J, Von Belkum A, Verburgh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-20. (Pubitemid 27359263)
3. Weems JJ, Beck LB. Nasal carriage of Staphylococcus aureus as a risk factor for skin and soft tissue infections. Curr Infect Dis Rep 2002; 4:420-5.
4. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of staphylococcus aureus bacteremia. N Engl J Med 2001, 344:11-6.
5. Naheed A, Saima S, Mobina D, Hayat A. Nasal carriage of Staphylococcus aureus in health care workers in Rawalpindi General Hospital. J Rawal Med Coll 2002; 6:74-6.
6. Kalsoom F, Zermina R, Akhtar N, Abdul Sattar, Khan JA, Bushra N. Nasal carriage of staphylococci in healthcare workers: antimicrobial susceptibility profile. Pak J Pharm Sci 2008; 21:290-4.
7. Ashiq B. The carrier state: methicillin-resistant Staphylococcus aureus. A hospital study "screening of hospital personnel" for nasal carriage of Staph. aureus. J Pak Med Assoc 1989; 39:35-8.
8. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003; 9:1179-86.
9. Cespedes C, Miller M, Quagliarello B, Vavagiakis P, Klein RS, Lowy FD. Differences between Staphylococcus aureus isolates from medical and non-medical hospital personnel. J Clin Microbiol 2002; 40:2594-7. (Pubitemid 34747367)
10. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
11. Vonberg RP, Stamm-Balderjahn S, Hansen S, Zuschneid I, Ruden H, Behnke M, et al. How often do asymptomatic healthcare workers cause methicillin-resistant Staphylococcus aureus outbreaks? A systematic evaluation. Infect Control Hosp Epidemiol 2006; 27:1123-7. Epub 2006 Sep 21.
12. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers ML, Matthys EG, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1993; 8:235-9.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests: approved standard. 9th ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2006.
14. Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus: a multicentre study. Indian J Med Microbiol 2006; 24:34-8. Comment in: Indian J Med Microbiol 2006; 24(4):304.
15. Lee YL, Cesario T, Tran C, Stone G, Thrupp L. Nasal colonization by methicillin-resistant coagulase-negative Staphylococcus in community skilled nursing facility patients. Am J Infect Control 2000; 28:269-72. (Pubitemid 30397526)
16. John JF Jr, Grieshop TJ, Atkins LM, Platt CG. Widespread colonization of personnel at a Veterans Affairs Medical Center by methicillin-resistant coagulase-negative Staphylococcus. Clin Infect Dis 1993; 17:380-8.
17. Silva FR, Mattos EM, Coimbra MVS, Ferreira-Carvalho BT, Figueiredo AM. Isolation and molecular characterization of methicillin-resistant coagulase-negative staphylococci from nasal flora of healthy humans at three community institutions in Rio de Janeiro city. Epidemiol Infect 2001; 127:57-62.
18. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48: 922-30.
19. Bischoff W, Bassetti S, Bassetti-Wyss BA, Wallis M, Tucker BK, Reboussin BA, et al. Airborne dispersal as a novel transmission route of coagulase-negative staphylococci: interaction between coagulase-negative staphylococci and rhinovirus infection. Infect Control Hosp Epidemiol 2004; 25:504-11.
20. Liakopoulos V, Petinaki E, Efthimiadi G, Klapsa D, Giannopoulou M, Dovas S, et al. Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece. Nephrol Dial Transplant 2008; 23:2599-603. Epub 2008 Feb 27.
21. Mitsuhashi S. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. J Antimicrob Chemother 1983; 12:53-64. (Pubitemid 14217855)
22. Pea F, Marioni G, Pavan F, Staffieri C, Bottin R, Staffieri A, et al. Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose. Pharmacol Res 2007; 55: 38-41. Epub 2006 Oct 10.
23. Takahashi H, Hayakawa I, Akimoto T. [The history of the development and changes of quinolone antibacterial agents]. Yakushigaku Zasshi 2003; 38:161-79. Japanese.
24. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-85. Epub 2006 Dec 14. Comment in: Curr Infect Dis Rep 2008; 10: 385-6.
25. Mandell GL, Moorman DR. Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. Antimicrob Agents Chemother 1980; 17:658-62.